Abrexa Pharmaceuticals Receives $500,793 New Funding
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ea414ebd-917d-495e-a611-151b516e1825&Preview=1 -
Date
9/8/2011 -
Company Name
Abrexa Pharmaceuticals -
Mailing Address
12481 High Bluff Drive San Diego, CA 92130 -
Company Description
Abrexa Pharmaceuticals is a stealth mode pharmaceutical development company. -
Website
Undisclosed
-
Transaction Type
Debt, Venture Equity -
Transaction Amount
$500,793 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. $742.60 of total amount sold is purchase price of common stock issued; $500,000 is purchase price of convertible promissory notes issued; and $50 is purchase price of warrants to purchase capital stock. SEC regulatory filing. -
M&A Terms
-
Venture Investor
Undisclosed
